These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 35693625

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
    Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Budaj A, Kiss RG, Padilla F, Gause-Nilsson I, Langkilde AM, Raz I, Sabatine MS, Wiviott SD.
    Circulation; 2020 Apr 14; 141(15):1227-1234. PubMed ID: 31983236
    [Abstract] [Full Text] [Related]

  • 4. Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials.
    Li D, Liu Y, Hidru TH, Yang X, Wang Y, Chen C, Li KHC, Tang Y, Wei Y, Tse G, Xia Y.
    Front Endocrinol (Lausanne); 2021 Apr 14; 12():619586. PubMed ID: 33815278
    [Abstract] [Full Text] [Related]

  • 5. SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.
    Li WJ, Chen XQ, Xu LL, Li YQ, Luo BH.
    Cardiovasc Diabetol; 2020 Aug 26; 19(1):130. PubMed ID: 32847602
    [Abstract] [Full Text] [Related]

  • 6. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.
    Li HL, Lip GYH, Feng Q, Fei Y, Tse YK, Wu MZ, Ren QW, Tse HF, Cheung BY, Yiu KH.
    Cardiovasc Diabetol; 2021 May 07; 20(1):100. PubMed ID: 33962654
    [Abstract] [Full Text] [Related]

  • 7. Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
    Yin Z, Zheng H, Guo Z.
    Front Cardiovasc Med; 2022 May 07; 9():902923. PubMed ID: 35665272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis.
    Li C, Yu J, Hockham C, Perkovic V, Neuen BL, Badve SV, Houston L, Lee VYJ, Barraclough JY, Fletcher RA, Mahaffey KW, Heerspink HJL, Cannon CP, Neal B, Arnott C.
    Diabetes Obes Metab; 2022 Oct 07; 24(10):1927-1938. PubMed ID: 35589614
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide Receptor Agonists for Atrial Fibrillation in Type 2 Diabetes Mellitus: Systematic Review With Network Meta-analysis of Randomized Controlled Trials.
    Li W, Chen X, Xie X, Xu M, Xu L, Liu P, Luo B.
    J Cardiovasc Pharmacol; 2022 Mar 01; 79(3):281-288. PubMed ID: 34935705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis.
    Shi W, Zhang W, Zhang D, Ren G, Wang P, Gao L, Chen H, Ding C.
    Heart Rhythm; 2021 Jul 01; 18(7):1090-1096. PubMed ID: 33684547
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
    Hu WS, Lin CL.
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep 01; 396(9):1977-1986. PubMed ID: 36881169
    [Abstract] [Full Text] [Related]

  • 16. Effect of SGLT2 inhibitors on cardiovascular events in patients with atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.
    Zheng S, Lai Y, Jiang C, He L, Zhao Z, Li W, Tang R, Sang C, Long D, Du X, Ma C, Dong J.
    Pacing Clin Electrophysiol; 2024 Jan 01; 47(1):58-65. PubMed ID: 38010824
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis.
    Xie X, Liu X, Chen B, Wang Q.
    Med Sci Monit Basic Res; 2018 Jun 30; 24():96-102. PubMed ID: 29959310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.